Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high ...
Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his confirmation? Follow along for updates.
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...
A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...
The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback